dc.contributor.author | MacManus, David G. | |
dc.contributor.author | Limmroth, Volker | |
dc.contributor.author | Polman, Chris H. | |
dc.contributor.author | Schmierer, Klaus | |
dc.contributor.author | Yousry, Tarek A. | |
dc.contributor.author | Meluzinova, Eva | |
dc.contributor.author | Dufek, Michal | |
dc.contributor.author | Yang, Minhua | |
dc.contributor.author | Dawson, Kate | |
dc.contributor.author | O'Neill, Gilmore N. | |
dc.contributor.author | Eraksoy, Mefkure | |
dc.contributor.author | Kappos, Ludwig | |
dc.contributor.author | Gold, Ralf | |
dc.contributor.author | Miller, David H. | |
dc.contributor.author | Havrdova, Eva | |
dc.date.accessioned | 2021-03-04T14:48:59Z | |
dc.date.available | 2021-03-04T14:48:59Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Kappos L., Gold R., Miller D. H. , MacManus D. G. , Havrdova E., Limmroth V., Polman C. H. , Schmierer K., Yousry T. A. , Eraksoy M., et al., "Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study", MULTIPLE SCLEROSIS JOURNAL, cilt.18, sa.3, ss.314-321, 2012 | |
dc.identifier.issn | 1352-4585 | |
dc.identifier.other | av_837d6510-8d02-4e5c-ab0d-e1c088c62db0 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/89506 | |
dc.identifier.uri | https://doi.org/10.1177/1352458511421054 | |
dc.description.abstract | Background: In a phase 2b study in patients with relapsing-remitting MS (RRMS), BG-12 240 mg three times daily significantly reduced the number of new gadolinium-enhanced (Gd+) lesions from weeks 12 to 24 (primary end point) by 69% compared with placebo. | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | NEUROSCIENCES | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Temel Bilimler | |
dc.title | Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study | |
dc.type | Makale | |
dc.relation.journal | MULTIPLE SCLEROSIS JOURNAL | |
dc.contributor.department | Universitaet Basel (University Of Basel) , , | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 314 | |
dc.identifier.endpage | 321 | |
dc.contributor.firstauthorID | 203765 | |